Relapsing Remitting Multiple Sclerosis Clinical Trials
2 recruiting trials for Relapsing Remitting Multiple Sclerosis. Eligibility criteria explained in plain English.
2
Total Trials
2
Recruiting Now
1
Phase 3 Trials
2
Sponsors
Recruiting Trials
RECRUITINGPhase 3NCT04047628
Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)
This is a multi-center prospective rater-masked (blinded) randomized controlled trial of 156 participants, comparing the treatment strategy of Autologous Hematopoietic Stem Cell...
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)Enrolling: 15620 locations
RECRUITINGNCT06663111
Rituximab and Ocrelizumab in Serum With Multiple Sclerosis
ROS-MS is a clinical pharmacological substudy to the OVERLORD-MS study (NCT04578639), designed to examine the possibilities of personalized treatment with rituximab and...
Sponsor: Haukeland University HospitalEnrolling: 601 location